Antihyperglycemic activity of Catharanthus roseus leaf powder in streptozotocin-induced diabetic rats
Karuna Rasineni1, Ramesh Bellamkonda2, Sreenivasa Reddy Singareddy1, Saralakumari Desireddy1★★ Corresponding author
- 1aDepartment of Biochemistry, Sri Krishnadevaraya University, Anantapur-515 003, Andhra Pradesh
- 2Department of Biochemistry, Sri Venkateswara University, Tirupati-517502, Andhra Pradesh, India
CORRESPONDENCE
Saralakumari Desireddy
*Address for correspondence: Saralakumari, Department of Biochemistry, Sri Krishnadevaraya University, Anantapur - 515 003, Andhra Pradesh, India.
Received: 06-01-2010; Revised: 20-02-2010; Accepted: 19-07-2010.
Volume 2, Issue 3 · pp. 195–202 · PUBLISHED January 2010 · DOI: 10.4103/0974-8490.65523
View on Pharmacogn. Res. original site ↗
ABSTRACT
Catharanthus roseus Linn (Apocynaceae), is a traditional medicinal plant used to control diabetes, in various regions of the world. In this study we evaluated the possible antidiabetic and hypolipidemic effect of C. roseus (Catharanthus roseus) leaf powder in diabetic rats. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ, 55 mg/kg body wt) to male Wistar rats. The animals were divided into four groups: Control, control-treated, diabetic, and diabetic-treated group. Diabetic-treated and control-treated rats were treated with C. roseus leaf powder suspension in 2 ml distilled water, orally (100 mg/kg body weight/day/60 days). In diabetic rats (D-group) the plasma glucose was increased and the plasma insulin was decreased gradually. In the diabetic-treated group lowering of plasma glucose and an increase in plasma insulin were observed after 15 days and by the end of the experimental period the plasma glucose had almost reached the normal level, but insulin had not. The significant enhancement in plasma total cholesterol, triglycerides, LDL and VLDL-cholesterol, and the atherogenic index of diabetic rats were normalized in diabetic-treated rats. Decreased hepatic and muscle glycogen content and alterations in the activities of enzymes of glucose metabolism (glycogen phosphorylase, hexokinase, phosphofructokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase), as observed in the diabetic control rats, were prevented with C. roseus administration. Our results demonstrated that C. roseus with its antidiabetic and hypolipidemic properties could be a potential herbal medicine in treating diabetes.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Rasineni, K., Bellamkonda, R., Singareddy, S. R., & Desireddy, S. (2010). Antihyperglycemic activity of Catharanthus roseus leaf powder in streptozotocin-induced diabetic rats. Pharmacognosy Research, 2(3), 195–202. https://doi.org/10.4103/0974-8490.65523
